This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/usa/521303-fauci-covid-booster-trials-underway/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Fauci says Covid vaccine booster trials 'ongoing already' for original coronavirus and South Africa variant | Fauci says Covid vaccine booster trials 'ongoing already' for original coronavirus and South Africa variant |
| (5 months later) | |
| Clinical trials are already being conducted into Covid-19 booster jabs for people who have already been vaccinated against the disease, America's Covid czar and infectious disease expert Dr. Anthony Fauci has said. | Clinical trials are already being conducted into Covid-19 booster jabs for people who have already been vaccinated against the disease, America's Covid czar and infectious disease expert Dr. Anthony Fauci has said. |
| The ongoing trials are looking at booster shots of vaccines against the original "wild type" coronavirus, as well as a variant-specific version for the South Africa B1.351 strain, Fauci said during a White House press briefing on Friday. | The ongoing trials are looking at booster shots of vaccines against the original "wild type" coronavirus, as well as a variant-specific version for the South Africa B1.351 strain, Fauci said during a White House press briefing on Friday. |
| He said the trials are focused on the "safety" of boosters and whether the extra jabs can increase the "ability of the antisera to ultimately neutralize both the wild type and the variant." | He said the trials are focused on the "safety" of boosters and whether the extra jabs can increase the "ability of the antisera to ultimately neutralize both the wild type and the variant." |
| This week, Fauci and Pfizer CEO Albert Bourla both said it is likely people will need a booster dose within 12 months of completing their original Covid vaccination schedule. | This week, Fauci and Pfizer CEO Albert Bourla both said it is likely people will need a booster dose within 12 months of completing their original Covid vaccination schedule. |
| ]Pfizer said in February it was testing a third booster dose of its Covid-19 vaccine, while Moderna has said that booster shots for its jab will be ready later this year. | ]Pfizer said in February it was testing a third booster dose of its Covid-19 vaccine, while Moderna has said that booster shots for its jab will be ready later this year. |
| Moderna last week gave the first doses of its variant-specific booster candidate for the South Africa variant to participants taking part in a US phase two clinical study. | Moderna last week gave the first doses of its variant-specific booster candidate for the South Africa variant to participants taking part in a US phase two clinical study. |
| The study of more than 200 people includes some 60 volunteers who have already received an initial dose of the drugmaker's vaccine and will be given a modified booster to assess its effect on the variant. | The study of more than 200 people includes some 60 volunteers who have already received an initial dose of the drugmaker's vaccine and will be given a modified booster to assess its effect on the variant. |
| In February, Pfizer announced the launch of a three-phase trial of the Covid vaccine it has developed with BioNTech to assess its efficacy against the South Africa variant. | In February, Pfizer announced the launch of a three-phase trial of the Covid vaccine it has developed with BioNTech to assess its efficacy against the South Africa variant. |
| A study earlier this year found that the South Africa variant may be more resistant to vaccines because it contains the E484K mutation in its spike protein, which researchers said can "moderately escape" the neutralizing effects of antibodies. | A study earlier this year found that the South Africa variant may be more resistant to vaccines because it contains the E484K mutation in its spike protein, which researchers said can "moderately escape" the neutralizing effects of antibodies. |
| South Africa suspended its use of AstraZeneca's vaccine in February due to the apparent ability of the indigenous variant to evade antibodies generated among the jab's recipients. | South Africa suspended its use of AstraZeneca's vaccine in February due to the apparent ability of the indigenous variant to evade antibodies generated among the jab's recipients. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |